FALCON Trial Informs the Evolving Role of Fulvestrant in Advanced Hormone Receptor–Positive Breast Cancer
The ASCO Post,
Advertisement Aman U. Buzdar, MD, FACP Endocrine therapy for breast cancer has evolved over the years.
Advertisement Aman U. Buzdar, MD, FACP Endocrine therapy for breast cancer has evolved over the years.
Aman U. Buzdar, MD, FACP Endocrine therapy for breast cancer has evolved over the years.
Action Points Note that this study was published as an abstract and presented at a conference.